Related Experiment Video
Updated: Jun 6, 2026

09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI)
Thomas M Atkinson1, Barry D Rosenfeld, Laura Sit
1Department of Psychiatry & Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. atkinsot@mskcc.org
Journal of Pain and Symptom Management
|December 7, 2010
Summary
The Brief Pain Inventory (BPI) may have a three-factor structure, including pain intensity, activity interference, and affective interference. This finding supports its use in clinical research for assessing patient-reported pain outcomes.
Area of Science:
- Psychometric validation
- Patient-reported outcomes
- Pain assessment
Background:
- The Brief Pain Inventory (BPI) is widely used for assessing patient-reported pain outcomes.
- Previous studies suggest a two-factor structure (pain intensity, pain interference) for the BPI.
- Confirmatory factor analysis (CFA) is appropriate for investigating the BPI's construct validity due to its a priori design.
Purpose of the Study:
- To establish the construct validity of the BPI using CFA.
- To demonstrate factorial invariance of the BPI across demographic variables.
Main Methods:
- A retrospective CFA was conducted on a sample of 364 individuals with HIV/AIDS and cancer.
- One-factor, two-factor, and three-factor models were compared.
- The three-factor model included pain intensity, activity interference, and affective interference.
Main Results:
- The three-factor model demonstrated statistically superior fit compared to the one-factor model.
- The three-factor model showed marginally better fit than the two-factor model.
- The three-factor structure was invariant across disease, age, and ethnicity groups.
Conclusions:
- Evidence supports a three-factor structure for the BPI, alongside the original two-factor hypothesis.
- These findings enhance confidence in the BPI's psychometric properties for clinical research.
- The study provides valuable insights for clinical trialists, pharmaceutical sponsors, and regulators.
